| Literature DB >> 29661157 |
Esther Viedma1, Dafne Pérez-Montarelo2, Jennifer Villa2, Irene Muñoz-Gallego2, Nieves Larrosa3, Nuria Fernández-Hidalgo3, Joan Gavaldà3, Benito Almirante3, Fernando Chaves2.
Abstract
BACKGROUND: The ability of Staphylococcus aureus to invade tissues and cause an infectious disease is the result of a multi-factorial process supported by the huge number of virulence factors inherent to this microorganism tightly regulated by the accessory gene regulator (agr). During antimicrobial therapy bacteria may be exposed to sub-inhibitory concentrations (subMICs) of antibiotics that may trigger transcriptional changes that may have an impact on the pathogenesis of infection. The objective of this study was to investigate the effect of oxacillin sub-MICs on agr system expression as the key component in the regulation of virulence in methicillin-susceptible (MSSA) and -resistant S. aureus (MRSA) strains. Furthermore, we studied the genetic basis of the agr locus and their potential association with the expression levels.Entities:
Keywords: Clonal complex; Oxacillin; Staphylococcus aureus; Sub-inhibitory concentrations; agr locus expression; agr mutations
Mesh:
Substances:
Year: 2018 PMID: 29661157 PMCID: PMC5902860 DOI: 10.1186/s12879-018-3088-7
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Clinical and genotypic characteristics of S. aureus strains and suboptimal concentration of oxacillin used in this study
| Strain | Clinical diagnosis | Clonal Complex |
| MIC oxacillin (mg/L) | sub_MIC oxacillin (mg/L) | |
|---|---|---|---|---|---|---|
| SA_123 | Infective endocarditis | CC45 | I | Negative | 0.38 | 0.02 |
| SA_520 | Infective endocarditis | CC45 | I | Negative | 0.50 | 0.03 |
| SA_170015 | Infective endocarditis | CC45 | I | Positive | 1.00 | 0.13 |
| SA_180015 | Infective endocarditis | CC8_ST8 | I | Negative | 0.25 | 0.03 |
| SA_190006 | Infective endocarditis | CC8_ST72 | I | Negative | 1.00 | 0.03 |
| SA_70002 | Infective endocarditis | CC8_ST72 | I | Positive | 2.00 | 0.13 |
| SA_80004 | Infective endocarditis | CC5_ST5 | II | Negative | 0.50 | 0.05 |
| SA_103 | Infective endocarditis | CC5_ST5 | II | Negative | 0.50 | 0.03 |
| SA_170006 | Infective endocarditis | CC5_ST125 | II | Positive | 256 | 8.00 |
| SA_180009 | Infective endocarditis | CC5_ST125 | II | Positive | 2.00 | 0.50 |
| SA_10009 | Infective endocarditis | CC15 | II | Negative | 0.38 | 0.19 |
| SA_10014 | Infective endocarditis | CC15 | II | Negative | 0.50 | 0.13 |
| SA_80001 | Infective endocarditis | CC30 | III | Negative | 0.25 | 0.05 |
| SA_107 | Catheter related bacteremia with septic complications | CC30 | III | Negative | 0.25 | 0.06 |
MIC minimal inhibition concentration
Fig. 1Effect of subMICs of oxacillin over RNAIII (a) and agrA (b) expression levels under oxacillin subMICs exposure in stationary growth phase. The expression levels of both agrA and RNAIII genes were determined by qRT–PCR experiments (three different experiments). The results are expressed as the n-fold variation of RNAIII (A) and agrA (B). An asterisk indicates a significant difference (P < 0.05)
Expression levels changes in RNAIII and agrA locus under the exposure to oxacillin subMICs in the stationary growth phase
|
|
| |||||
|---|---|---|---|---|---|---|
| Strain | subMIC OXAa vs. No subMIC OXA | P b;c | subMIC OXA vs. No subMIC OXA | P | ||
| SA_123 | 1.08 | NEG | 0.735 | 1.71 | POS | 0.128 |
| SA_520 | 1.62 | POS |
| 1.69 | POS |
|
| SA_170015 | 2.11 | POS |
| 1.51 | POS | 0.116 |
| SA_180015 | 3.88 | POS |
| 1.65 | POS | 0.138 |
| SA_190006 | 1.19 | POS | 0.465 | 1.46 | POS | 0.080 |
| SA_70002 | 1.12 | POS | 0.144 | 1.99 | POS | 0.144 |
| SA_80004 | 2.90 | POS |
| 2.55 | POS |
|
| SA_103 | 1.32 | POS | 0.465 | 1.13 | NEG | 0.465 |
| SA_170006 | 3.69 | NEG |
| 1.12 | POS | 0.398 |
| SA_180009 | 20.58 | POS | 0.068 | 5.63 | POS |
|
| SA_10009 | 4.23 | POS |
| 8.91 | POS |
|
| SA_10014 | 1.43 | POS | 0.091 | 1.65 | POS |
|
| SA_80001 | 1.31 | POS | 0.249 | 1.34 | NEG |
|
| SA_107 | 12.08 | NEG |
| 1.37 | NEG | 0.345 |
a OXA: Oxacillin
b POS: fold change positive in the expression level under exposure to oxacillin subMIC. NEG: fold change negative in the expression level under exposure to oxacillin subMICs
c Bold numbers indicate statistical significant results (P < 0.05)
Expression levels changes in RNAIII and agrA locus under exposure to oxacillin subMICs in the stationary growth phase clustered by methicillin resistance; Clonal Complex and agr type
|
|
| |||||
|---|---|---|---|---|---|---|
| subMIC OXA a vs. No subMIC OXA | P b;c | subMIC OXA vs. No subMIC OXA | P | |||
| Methicillin resistance | ||||||
| MRSA | 2.26 | POS | 0.051 | 1.80 | POS | 0.163 |
| MSSA | 1.75 | POS | 0.149 | 1.82 | POS |
|
| Clonal complex | ||||||
| CC45 | 1.74 | POS |
| 1.61 | POS |
|
| CC8 | 1.07 | NEG | 1.000 | 1.81 | POS |
|
| CC5 | 2.36 | POS | 0.108 | 3.61 | POS |
|
| CC15 | 3.48 | POS |
| 4.48 | POS |
|
| CC30 | 7.16 | NEG | 0.071 | 1.32 | NEG | 0.138 |
| | 1.10 | POS | 0.804 | 1.62 | POS |
|
| | 3.95 | POS |
| 3.98 | POS |
|
| | 7.16 | NEG | 0.071 | 1.32 | NEG | 0.138 |
a OXA: Oxacillin
b POS: fold change positive in the expression level under exposure to oxacillin subMIC. NEG: fold change negative in the expression level under exposure to oxacillin subMICs
c Bold numbers indicate statistical significant results (P < 0.05)
Clustering of agr locus mutations among clones and agr genotypes
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Strain | CC a | SNP b (N°) | Non-synonymous predicted result | SNP (N°) | Non-synonymous predicted result | SNP (N°) | Non-synonymous predicted result | SNP (N°) | Non-synonymous predicted result | Reference | |
| SA_123 | CC45 | 1 | 35 | t329c (110 Ile > Thr); | 5 | – | 26 | t125g (42 Val > Gly); | 19 | – | NCTC8325 |
| SA_520 | CC45 | 1 | 30 | t329c (110 Ile > Thr); | 5 | – | 25 | t125g (42 Val > Gly); | 19 | – | NCTC8325 |
| SA_170015 | CC45 | 1 | 30 | t329c (110 Ile > Thr); | 5 | – | 26 | t125g (42 Val > Gly); | 19 | – | NCTC8325 |
| SA_180015 | CC8 | 1 | – | – | – | – | a409 (138Lys/del -1 bp) | 2 | – | NCTC8325 | |
| SA_190006 | CC8 | 1 | – | – | – | – | 24 | t125g (42 Val > Gly); | 2 | – | NCTC8325 |
| SA_70002 | CC8 | 1 | – | – | – | – | 24 | t125g (42 Val > Gly); | 2 | – | NCTC8325 |
| SA_103 | CC5 | 2 | – | – | – | – | 1 | c287t (96; Ser > Leu) | – | – | N315 |
| SA_80004 | CC5 | 2 | – | – | – | – | 1 | t313 (138 Phe/del -1 bp) | – | – | N315 |
| SA_170006 | CC5 | 2 | – | – | – | – | 1 | t361c (121; I > T) | – | – | N315 |
| SA_180009 | CC5 | 2 | – | – | – | – | – | – | – | – | N315 |
| SA_10009 | CC15 | 2 | 1 | – | – | – | 11 | – | 5 | a407g (136 Lys > Arg) | N315 |
| SA_10014 | CC15 | 2 | 1 | – | – | – | 11 | – | 5 | a407g (136 Lys > Arg) | N315 |
| SA_80001 | CC30 | 3 | 13 | a145c (49 Ile/Leu); | 3 | – | 7 | g163a (55 Gly > Arg) | 12 | – | MW2 |
| SA_107 | CC30 | 3 | 13 | a145c (49 Ile/Leu); | 3 | – | 7 | g163a (55 Gly > Arg) | 12 | – | MW2 |
a Clonal Complex
Total number of single nucleotide polymorphism including synonymous and non-synonymous mutations
Fig. 2Relative expression of RNAIII (a) and agrA (b) in stationary growth phase. The expression levels of both agrA and RNAIII genes were determined by qRT–PCR experiments. The values are the means ± standard deviation (three different experiments)
Relationship between mutations detected and relative expression levels of agr locus
|
|
| |||||
|---|---|---|---|---|---|---|
| Mutations | Strains | CC a | Absence vs Presence b |
| Absence vs Presence | P |
| 42Val > Gly | SA_123; SA_520; SA_170015; SA_190006; SA_70002 | 45; 8 | 8.11 ± 14.27 vs. 40.22 ± 51.37 |
| 0.76 ± 0.53 vs. 5.26 ± 3.46 |
|
| 251Tyr > Phe | SA_123; SA_520; SA_170015 | 45 | 19.58 ± 39.28 vs. 16.90 ± 9.73 | 0.597 | 1.92 ± 3.16 vs. 3.51 ± 1.22 |
|
| 417Glu > Lys | SA_123 | 45 | 19.88 ± 36.58 vs. 8.66 ± 3.83 | 0.422 | 2.03 ± 2.96 vs. 4.57 ± 1.04 |
|
| 103I > T | SA_170015 | 45 | 18.49 ± 36.39 vs. 27.16 ± 8.56 | 0.563 | 2.21 ± 3.03 vs. 2.94 ± 0.74 | 0.556 |
| 138Lys/del-1 bp) | SA_180015 | 8 | 20.56 ± 36.30 vs. 0.22 ± 0.05 |
| 2.40 ± 2.99 vs. 0.26 ± 0.89 |
|
| 262Asp > Ala | SA_190006; SA_70002 | 8 | 10.17 ± 13.81 vs. 74.29 ± 67.51 |
| 1.42 ± 1.40 vs. 8.27 ± 4.01 |
|
| 258Phe > Ile | SA_190006; SA_70002 | 8 | 10.17 ± 13.81 vs. 74.29 ± 67.51 |
| 1.42 ± 1.40 vs. 8.27 ± 4.01 |
|
| 138Phe/del-1 bp) | SA_80004 | 5 | 20.80 ± 36.44 vs. 0.14 ± 0.04 |
| 2.41 ± 2.41 vs. 0.16 ± 0.85 |
|
| 96Ser > Leu | SA_103 | 5 | 20.47 ± 36.35 vs.1.29 ± 0.56 |
| 2.42 ± 3.02 vs 0.56 ± 0.27 |
|
| 121I > T | SA_170006 | 5 | 20.53 ± 36.31 vs. 0.51 ± 0.24 |
| 2.42 ± 3.00 vs 0.36 ± 0.75 |
|
| 136Lys > Arg | SA_10009; SA_10014 | 15 | 17.91 ± 37.60 vs. 25.01 ± 19.04 | 0.478 | 2.49 ± 3.16 vs 1.08 ± 0.32 |
|
| 55Gly > Arg | SA_80001; SA_107 | 30 | 20.86 ± 37.41 vs. 6.59 ± 6.82 |
| 2.40 ± 3.12 vs 1.33 ± 0.52 |
|
a Clonal Complex
b Values of expression are showed as relative means ± standard deviation (SD) according to the presence and absence of mutation detected relative to the agr group reference strains
c Bold numbers indicate statistical significant results (P < 0.05)